Search - tctmd.com

Displaying 121 - 140 of 275

Sort: Relevancy | Date

News Conference News TCT 2018

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

TCT Daily Staff

September 28, 2018

Presentation TCT 2018

Case #5: A Case in Which We Pushed the Envelope to Complete a Transfemoral TAVR

Presenter: Philippe Genereux, Josep Rodés-Cabau, Suzanne V. Arnold, Wayne B. Batchelor, Pablo Lamelas, Tullio Palmerini, Shigeru Saito, Tobias Tichelbäcker

September 23, 2018

Presentation TCT 2018

TCT-42: An Early Feasibility Study to Assess Safety and Effectiveness of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)

Presenter: David Hildick-Smith, Martin B. Leon, Hendrik Treede

September 21, 2018

News Daily News

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Michael O'Riordan

September 20, 2018

News Daily News

TAVR Without Balloon Aortic Valvuloplasty: Increasingly Common, With Similar Outcomes

Yael L. Maxwell

September 17, 2018

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

News Daily News

TAVR Learning Curve, Volume-Outcome Relationship Highlighted in International Registry

Todd Neale

September 11, 2018

News Daily News

Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality

Todd Neale

July 18, 2018

News Daily News

No Harm Done: Foregoing Routine TEE and General Anesthesia in TAVR

Caitlin E. Cox

July 17, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2018

Shelley Wood

July 02, 2018

News Conference News The Structural Heart Disease Summit 2018

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Shelley Wood

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Shelley Wood

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Large Hole Transfemoral Closure III: The MANTA Device

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Large Hole Transfemoral Closure II: The InSeal Device

Presenter: Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Large Hole Transfemoral Closure I: The PerQseal Device

Presenter: Jeffrey J. Popma

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Intravascular Lithotripsy Facilitated Transfemoral TAVR After Subclavian Arterial Access Failure

Presenter: Howard C. Herrmann, Fabian Nietlispach, Chandan Devireddy, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Ten Tips to Achieve Optimal Percutaneous Transfemoral Access and Closure for TAVR

Presenter: Isaac George, James M. McCabe, Jonathon M. White

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Presenter: Eberhard Grube, Tamim Nazif, Chetan P. Huded

June 21, 2018

News Conference News EuroPCR 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Caitlin E. Cox

May 25, 2018

News Conference News SCAI 2018

Longer Hospital Stays After TAVR Associated With Worse Outcomes

L.A. McKeown

April 27, 2018

Advertisement

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

Case #5: A Case in Which We Pushed the Envelope to Complete a Transfemoral TAVR

TCT-42: An Early Feasibility Study to Assess Safety and Effectiveness of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

TAVR Without Balloon Aortic Valvuloplasty: Increasingly Common, With Similar Outcomes

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

TAVR Learning Curve, Volume-Outcome Relationship Highlighted in International Registry

Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality

No Harm Done: Foregoing Routine TEE and General Anesthesia in TAVR

TCTMD’s Top 10 Most Popular Stories for June 2018

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Large Hole Transfemoral Closure III: The MANTA Device

Large Hole Transfemoral Closure II: The InSeal Device

Large Hole Transfemoral Closure I: The PerQseal Device

Intravascular Lithotripsy Facilitated Transfemoral TAVR After Subclavian Arterial Access Failure

Ten Tips to Achieve Optimal Percutaneous Transfemoral Access and Closure for TAVR

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Longer Hospital Stays After TAVR Associated With Worse Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content